Cancer Immunotherapy via Disruption of Integrin αvβ3 and CD47 Costabilization on Cancer Cell Surface
This study identifies a cancer‐specific interaction between CD47 and integrin αvβ3 that facilitates immune evasion. A rationally designed peptide, PSFL‐NK13, disrupts this axis, enhancing macrophage‐mediated phagocytosis and suppressing tumor growth without inducing anemia.
Peng‐Cheng Yu +12 more
wiley +1 more source
Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy. [PDF]
Du F +14 more
europepmc +1 more source
This study uncovers a new allosteric site in the Josephin domain of ataxin‐3 targeted by the molecular tweezer CLR01, which modulates protein aggregation, improves synaptic function in neuronal cells, and delays motor dysfunction in animal models.
Alexandra Silva +28 more
wiley +1 more source
Circular RNA PTPN4 Contributes to Blood‐Brain Barrier Disruption during Early Epileptogenesis
Epileptic condition induces CircPTPN4 upregulation, which promotes ECE‐1 expression through competitive sequestration of miR‐145a‐5p. The elevated ECE‐1 catalyzes the ET‐1 production, leading to p38/MAPK pathway activation and subsequent downregulation of tight junction protein expression. This cascade results in increased BBB permeability and enhanced
Jiurong Yang +16 more
wiley +1 more source
Glutaminase inhibitor CB-839 causes metabolic adjustments in colorectal cancer cells. [PDF]
Spada M +13 more
europepmc +1 more source
The tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2. [PDF]
Shao D +5 more
europepmc +1 more source
High matrix stiffness triggers the YAP-OPA1-TET1/3 loop to drive chemoresistance via enhanced nuclear-mitochondrial communication. [PDF]
Wu P +11 more
europepmc +1 more source
Metabolic nanoblockers for synergistic cancer treatment through glutaminase inhibition and sonodynamic therapy. [PDF]
Zhao W +6 more
europepmc +1 more source
Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies. [PDF]
Guo C, Wang C.
europepmc +1 more source

